Drug
TG103
TG103 is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
2
40%
Ph phase_2
1
20%
Ph phase_1
2
40%
Phase Distribution
2
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)
Trials by Status
completed240%
unknown240%
active_not_recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
completedphase_3
A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus
NCT06258148
active_not_recruitingphase_3
A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
NCT06235086
unknownphase_2
A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes
NCT05063253
unknownphase_1
A Study of TG103 in Subjects With Type 2 Diabetes
NCT04790006
completedphase_1
A Study of TG103 in Chinese Healthy Adult Subjects
NCT03990090
Clinical Trials (5)
Showing 5 of 5 trials
NCT06258148Phase 3
A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus
NCT06235086Phase 3
A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
NCT05063253Phase 2
A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes
NCT04790006Phase 1
A Study of TG103 in Subjects With Type 2 Diabetes
NCT03990090Phase 1
A Study of TG103 in Chinese Healthy Adult Subjects
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5